Drugs that contain Sonidegib Phosphate

1. Drug name - ODOMZO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8178563 SUN PHARM Compounds and compositions as hedgehog pathway modulators
Jul, 2029

(6 years from now)

US8063043 SUN PHARM Salts of N-[6-cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4′-(trifluoromethoxy)[1,1′-biphenyl]-3-carboxamide
Sep, 2029

(6 years from now)

CN101437800A SUN PHARM Compounds And Compositions As Hedgehog Pathway Modulators
Sep, 2013

(9 years ago)

CN102746285B SUN PHARM Compounds And Compositions As Hedgehog Pathway Modulators
May, 2027

(4 years from now)

CN102746285A SUN PHARM Compounds And Compositions Used As Hedgehog Pathway Modulators
May, 2027

(4 years from now)

CN102159570A SUN PHARM Salts Of N-[6-Cis-2,6-Dimethylmorpholin-4Yl)Pyridine-3Yl]-2-Methyl-4'-(Trifluoromethoxy)[1,1'-Biphenyl]-3-Carboxamide
Sep, 2029

(6 years from now)

CN102159570B SUN PHARM Salts Of N-[6-Cis-2,6-Dimethylmorpholin-4Yl)Pyridine-3Yl]-2-Methyl-4'-(Trifluoromethoxy)[1,1'-Biphenyl]-3-Carboxamide
Sep, 2029

(6 years from now)

IN301047B SUN PHARM N-(6-((2R, 6S)-2,6-Diethylmorpholino)Pyridin-3-Yl)-2-Methyl-4'- (Trifluoromethoxy)Biphenyl-3-Carboxamide
May, 2027

(4 years from now)

IN200809437P1 SUN PHARM Compounds And Compositions As Hedgehog Pathway Modulators
May, 2027

(4 years from now)

EP2363393B1 SUN PHARM Compounds And Compositions As Hedgehog Pathway Modulators
May, 2027

(4 years from now)

EP2363393A1 SUN PHARM Compounds And Compositions As Hedgehog Pathway Modulators
May, 2027

(4 years from now)

EP2021328A2 SUN PHARM Compounds And Compositions As Hedgehog Pathway Modulators
May, 2027

(4 years from now)

EP2021328B1 SUN PHARM Compounds And Compositions As Hedgehog Pathway Modulators
May, 2027

(4 years from now)

EP2342198A1 SUN PHARM A Diphosphate Salt Of N-[6-Cis-2,6-Dimethylmorpholin-4Yl)Pyridine-3Yl]-2-Methyl-4'-(Trifluoromethoxy)[1,1'-Biphenyl]-3-Carboxamide
Sep, 2029

(6 years from now)

EP2342198B1 SUN PHARM A Diphosphate Salt Of N-[6-Cis-2,6-Dimethylmorpholin-4Yl)Pyridine-3Yl]-2-Methyl-4'-(Trifluoromethoxy)[1,1'-Biphenyl]-3-Carboxamide
Sep, 2029

(6 years from now)

Treatment: NA

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 200MG BASE CAPSULE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.